Compare IBRX & TTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IBRX | TTEK |
|---|---|---|
| Founded | 2014 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Military/Government/Technical |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | 7.9B |
| IPO Year | 2015 | 1995 |
| Metric | IBRX | TTEK |
|---|---|---|
| Price | $7.41 | $31.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | $12.57 | ★ $44.00 |
| AVG Volume (30 Days) | ★ 14.7M | 2.2M |
| Earning Date | 05-11-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.83% |
| EPS Growth | ★ 38.71 | N/A |
| EPS | N/A | ★ 0.40 |
| Revenue | $113,288,000.00 | ★ $2,964,148,000.00 |
| Revenue This Year | $88.59 | N/A |
| Revenue Next Year | $131.15 | $6.43 |
| P/E Ratio | ★ N/A | $78.33 |
| Revenue Growth | ★ 668.31 | 7.66 |
| 52 Week Low | $1.83 | $29.57 |
| 52 Week High | $12.43 | $43.14 |
| Indicator | IBRX | TTEK |
|---|---|---|
| Relative Strength Index (RSI) | 46.98 | 45.07 |
| Support Level | $2.22 | $29.72 |
| Resistance Level | $8.28 | $34.96 |
| Average True Range (ATR) | 0.56 | 0.94 |
| MACD | 0.06 | 0.19 |
| Stochastic Oscillator | 39.03 | 53.32 |
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
Tetra Tech Inc provides consulting and engineering services for environmental, infrastructure, resource management, energy, and international development markets. It specializes in providing water-related services for public and private clients. It designs infrastructure, facilities, and other structures with complex plans and resource management. it has two reportable segments. Its Government Services Group (GSG) segment includes activities with U.S. government clients (federal, state and local) and activities with development agencies world-wide. Commercial/International Services Group (CIG) segment, which derives maximum revenue, includes activities with U.S. commercial clients and international clients other than development agencies.